An advanced liver endocrine factor analog with capacity to mitigate blood sugar spikes and thus potentially contributing to logevity depending on current metabolic function and health pattern of the user.
Alcydon develops and explores the application of the GeoReactor GRX01; together with Nature it will form a strong ensemble of advanced combined energy supply of process heat for continuous chemical reactions on the one hand and electricity on the other. The systems are compatible, complementary and can multiply.
Alcydon initiates research into to the relevance of developing a cell and gene therapy division. The aim is to achieve excellent, accessible and affordable solutions for everyone who needs them. In complete synergy and symmetry with the Alcydon XTL product line, 8 solutions will also be addressed here; namely CGT1, CGT2, CGT3, CGT4, CGT5, CGT6, CGT7 and CGT8. The last in line will be particularly focused on possible life extension.
Open for collaboration.
This research will investigate whether, in addition to potentially improved muscle integrity and strentgh, improved overall growth can also be achieved, and whether side effects of glucocorticoïds can be mitigated.
Open for collaboration.
Alcydon starts creating momentum in an energy-access-for-all program focused on Central Africa. Energy access isn't just about lights; it's a foundational tool for peace, economic empowerment.
Open for collaboration.
The new facility will focus on the production of nutritional supplements, nutriceuticals.
An innovative concept around vertical farming will be incorporated into the design from the outset, together with the development of a CCR building material.
The design and optimization of production lines will be driven by automotive production line technology from Detroit.
Veterans are encouraged to participate in the project.